Literature DB >> 8239051

Efficacy evaluation of a 4% chlorhexidine gluconate as a full-body shower wash.

D S Paulson1.   

Abstract

A 4% chlorhexidine gluconate (Xttrium Laboratories, Chicago, Ill.) was used in a shower bath application to evaluate its merits in reducing resident skin microorganisms. Five volunteers completed a 14-day microbial stabilization period, a 7-day baseline period, and a 5-day test period. Subjects followed a standard protocol, performed five shower washes and were sampled at both the abdominal and inguinal regions immediately after the shower wash as well as at 3 and 6 hours later on days 1, 2, and 5. Chlorhexidine gluconate provided significant microbial reductions from baseline, with greater reductions noted as the study progressed. Use of chlorhexidine gluconate in a shower wash application in conjunction with a preoperative skin-preparation procedure may reduce the probability of surgically associated infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239051     DOI: 10.1016/0196-6553(93)90033-z

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  10 in total

1.  Opportunities and Obstacles in the Prevention of Skin and Soft-Tissue Infections Among Military Personnel.

Authors:  Eugene V Millar; Carey D Schlett; Natasha N Law; Timothy J Whitman; Michael W Ellis; David R Tribble; Jason W Bennett
Journal:  Mil Med       Date:  2019-11-01       Impact factor: 1.437

Review 2.  Surgical site infection prevention: how we do it.

Authors:  Tjasa Hranjec; Brian R Swenson; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2010-06       Impact factor: 2.150

3.  Should preoperative showering or cleansing with chlorhexidine gluconate (CHG) be part of the surgical care bundle to prevent surgical site infection?

Authors:  Charles E Edmiston; David Leaper
Journal:  J Infect Prev       Date:  2017-07-26

4.  Differential actions of chlorhexidine on the cell wall of Bacillus subtilis and Escherichia coli.

Authors:  Hon-Yeung Cheung; Matthew Man-Kin Wong; Sau-Ha Cheung; Longman Yimin Liang; Yun-Wah Lam; Sung-Kay Chiu
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

5.  [Quality assurance and infection control in outpatient surgery].

Authors:  A Blaich; R Babikir; F Daschner; M Schweins; J Lambert; E Ingenhoven; P Gastmeier; M Dettenkofer
Journal:  Chirurg       Date:  2007-07       Impact factor: 0.920

Review 6.  Hygiene of the skin: when is clean too clean?

Authors:  E Larson
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

Review 7.  Use of Chlorhexidine Preparations in Total Joint Arthroplasty.

Authors:  Jaiben George; Alison K Klika; Carlos A Higuera
Journal:  J Bone Jt Infect       Date:  2017-01-01

8.  Does a quality improvement campaign accelerate take-up of new evidence? A ten-state cluster-randomized controlled trial of the IHI's Project JOINTS.

Authors:  Eric C Schneider; Melony E Sorbero; Ann Haas; M Susan Ridgely; Dmitry Khodyakov; Claude M Setodji; Gareth Parry; Susan S Huang; Deborah S Yokoe; Don Goldmann
Journal:  Implement Sci       Date:  2017-04-17       Impact factor: 7.327

Review 9.  Zinc pyrithione in alcohol-based products for skin antisepsis: persistence of antimicrobial effects.

Authors:  Eugene Guthery; Lawton A Seal; Edward L Anderson
Journal:  Am J Infect Control       Date:  2005-02       Impact factor: 2.918

10.  Risk Factors for Wound Infections after Vascular Surgery: Kuwait Experience.

Authors:  Abdullah A AlFawaz; Ali H Safar; Ali Al-Mukhaizeem; Emad Kamal; Mohammed Alloush; Ebrahim Hanbal
Journal:  Med Princ Pract       Date:  2022-05-19       Impact factor: 2.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.